ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Trevicta 350 mg/1.75 ml, Depot-Injektionssuspension in einer Fertigspritze - 
66054003 Janssen-Cilag AG
Trevicta 350 mg/1.75 ml, Depot-Injektionssuspension in einer Fertigspritze16.11.2016
  16.11.2016
Paliperidone (N05AX13) 
WHO-DDD 
01.05. 
01.05. 
B  
Yes 
IP 
1205.13No
    
10 %1327.05
  
7680660540035Synthetika
6869621 
Composition
paliperidonum 350 mg ut paliperidoni palmitas 546 mg, polysorbatum 20, macrogolum 4000, acidum citricum monohydricum, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 1.75 ml corresp. natrium 7.18 mg.
Packungsbestandteile
Retardsuspension zur intramuskulären Injektion 
  
 
Active AgentDose
Paliperidonum350mg / 1.75ml
BAG: Active AgentDose
Paliperidonum350 mg
 
Inactive agentsDose
Citric Acid Monohydrate 
Macrogol4000
Sodium Dihydrogenophosphate Monohydrate 
Sodium Hydroxide 
Polysorbatum 20 
 
Source
Data was imported : 06.11.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home